Comparison of microarray analysis of fine needle aspirates and tissue specimen in thyroid nodule diagnosis

Diagnostic Molecular Pathology

Volumn 19, Issue 1, 2010, Pages 9-14

  Kundel, Anna ^a   Zarnegar, Rasa ^a   Kato, Meredith ^a   Moo, Tracy Ann ^a   Zhu, Biaxin ^a   Scognamiglio, Theresa ^a   Fahey, Thomas J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Diagnosis; FNA; Microarray; Thyroid cancer; Thyroid nodule

Indexed keywords

COMPLEMENTARY DNA; RNA;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CLUSTER ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RELIABILITY; THYROID ADENOMA; THYROID CANCER; THYROID GLAND; THYROID NODULE;

ADULT; AGED; BIOPSY; DNA, COMPLEMENTARY; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NODULE; YOUNG ADULT;

EID: 77749330907     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181ae870c     Document Type: Article

References (35)

1. Huerta S. Recent adVances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn. 2008;8:277-288.
2. Mullan PB, Millikan RC. Molecular subtyping of breast cancer: opportunities for new therapeutic approaches. Cell Mol Life Sci. 2007;64:3219-3232.
3. Segal NH, Pavlidis P, Antonescu CR, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol. 2003;163:691-700.
4. Wellmann A, Thieblemont C, Pittaluga S, et al. Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood. 2000;96:398-404.
5. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
6. Huang Y, Prasad M, Lemon WJ, et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA. 2001;98:15044-15049.
7. Finley DJ, Zhu B, BarDen CB, et al. Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg. 2004;240:425-436; discussion 436-437.
8. Finley DJ, Arora N, Zhu B, et al. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab. 2004;89:3214-3223. (Pubitemid 38951886)
9. Mazzanti C, Zeiger MA, Costouros NG, et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res. 2004;64:2898-2903.
10. Jarzab B, Wiench M, Fujarewicz K, et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res. 2005;65:1587-1597.
11. Giordano TJ, Kuick R, Thomas DG, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/ PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24:6646-6656.
12. Melillo RM, Castellone MD, Guarino V, et al. The RET/PTC-RASBRAF linear signaling cascaDe mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest. 2005;115:1068-1081.
13. Baloch ZW, Sack MJ, Yu GH, et al. Fine-needle aspiration of thyroid: an institutional experience. Thyroid. 1998;8:565-569.
14. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: adVantages, limitations, and effect. Mayo Clin Proc. 1994;69:44-49.
15. Caraway NP, Sneige N, Samaan NA. Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol. 1993;9:345-350.
16. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am. 1997;26:777-800.
17. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425-437.
18. Eszlinger M, Krohn K, Kukulska A, et al. Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. Endocr Rev. 2007;28:322-338.
19. Kelman AS, Rathan A, Leibowitz J, et al. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in inDeterminate specimens. Thyroid. 2001;11:271-277.
20. Banks ND, Kowalski J, Tsai HL, et al. A diagnostic predictor moDel for inDeterminate or suspicious thyroid FNA samples. Thyroid. 2008;18:933-941.
21. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118:282-289.
22. Lubitz CC, Ugras SK, Kazam JJ, et al. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn. 2006;8:490-498; quiz 528.
23. Symmans WF, Ayers M, Clark EA, et al. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer. 2003;97:2960-2971.
24. West RB, Van De Rijn M. The role of microarray technologies in the study of soft tissue tumours. Histopathology. 2006;48:22-31.
25. Gruvberger S, Ringner M, Chen Y, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001;61:5979-5984.
26. Lee YF, John M, Edwards S, et al. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer. 2003;88:510-515.
27. Su YA, Bittner ML, Chen Y, et al. IDentification of tumorsuppressor genes using human melanoma cell lines UACC903, UACC903 (+6), and SRS3 by comparison of expression profiles. Mol Carcinog. 2000;28:119-127.
28. Hassan S, Ferrario C, Mamo A, et al. Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol. 2008;19: 19-25.
29. Aguilar-Mahecha A, Hassan S, Ferrario C, et al. Microarrays as validation strategies in clinical samples: tissue and protein microarrays. OMICS. 2006;10:311-326.
30. Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001;10:657-662.
31. Ewis AA, Zhelev Z, Bakalova R, et al. A history of microarrays in biomedicine. Expert Rev Mol Diagn. 2005;5:315-328.
32. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989;63:908-911.
33. Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer. 2000;90:357-363.
34. Polyzos SA, Kita M, Goulis DG, et al. EpiDemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004). Exp Clin Endocrinol Diabetes. 2008;116:496-500.
35. Amrikachi M, Ramzy I, Rubenfeld S, et al. Accuracy of fineneedle aspiration of thyroid. Arch Pathol Lab Med. 2001;125: 484-488.